The present analysis provides, from everyday practice over a long term in a large cohort, further evidence of the value of 68Ga-PSMA-11 PET/CT in localizing lesions suspicious for prostate cancer in prostatectomized patients with BCR but very low PSA levels. This evidence concerns the gene BCR and prostate cancer.